GALERA THERAPEUTICS INC
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GRTX and buy or sell other stocks, ETFs, and their options commission-free!About GRTX
Galera Therapeutics, Inc. is a clinical stage biotechnology company, which engages in developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. It is also involved in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis, and cancer.
CEOJohn Mel Sorensen
CEOJohn Mel Sorensen
Employees3
Employees3
HeadquartersMalvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded2009
Founded2009
Employees3
Employees3
GRTX Key Statistics
Market cap1.81M
Market cap1.81M
Price-Earnings ratio-0.18
Price-Earnings ratio-0.18
Dividend yield—
Dividend yield—
Average volume37.57K
Average volume37.57K
High today$0.0283
High today$0.0283
Low today$0.024
Low today$0.024
Open price$0.024
Open price$0.024
Volume38.13K
Volume38.13K
52 Week high$0.0598
52 Week high$0.0598
52 Week low$0.0151
52 Week low$0.0151
Stock Snapshot
With a market cap of 1.81M, GALERA THERAPEUTICS INC(GRTX) trades at $0.02. The stock has a price-to-earnings ratio of -0.18.
On 2025-12-07, GALERA THERAPEUTICS INC(GRTX) stock moved within a range of $0.02 to $0.03. With shares now at $0.02, the stock is trading 0.0% above its intraday low and -15.2% below the session's peak.
Trading volume for GALERA THERAPEUTICS INC(GRTX) stock has reached 38.13K, versus its average volume of 37.57K.
The stock's 52-week range extends from a low of $0.02 to a high of $0.06.
The stock's 52-week range extends from a low of $0.02 to a high of $0.06.
People also own
Based on the portfolios of people who own GRTX. This list is generated using Robinhood data, and it’s not a recommendation.